About Intusomics Analytics

Founded by Daniel Arenas, Intusomics Analytics was built to address a recurring issue in omics projects: data generation at scale is often paired with analysis that prioritizes speed and standardization over study-specific biology. One-size-fits-all settings can miss subtle signals, especially when a project needs deeper handling (for example, batch-effect correction, clinical-study-aware endpoints, or updated methods tailored to the design).

Intusomics Analytics takes a different approach. We design the analysis strategy around your experimental setup, sample type, and biological question—adapting parameters and tools when your dataset requires it, and going beyond “processing” to deliver results you can trust and act on.

We support academic labs, startups, and biotech teams who need more than a generic pipeline. Clients work with us for high-touch collaboration and clear interpretation that enables decisions—strengthening a manuscript, prioritizing biomarkers, or de-risking an R&D program.

In addition to rigorous computation, we provide biological interpretation, recommended next experimental steps, and publication-ready figures—so your sequencing investment translates into actionable insight, not just outputs.

FAQs

What makes Intusomics Analytics different from other bioinformatics services?

Unlike traditional data processing firms, Intusomics Analytics is built on active molecular biology research and deep expertise in biomedical mechanisms. We don't just run algorithms; we understand the biological systems that generate your data. Our team combines wet-lab experimental experience (cell culture, transfection, Western blotting, sequencing protocols) with advanced computational analysis, ensuring that our insights are biologically sound, statistically rigorous, and publication-ready.

Who We Serve?
How is data integrity ensured?
Can I get support?

Our tools handle RNA-seq, genomics, and other complex datasets with rigorous methods.

We partner with academic research laboratories, biotech startups, pharmaceutical companies, and clinical research centers. Whether you're a principal investigator seeking expert analysis of complex transcriptomic datasets, a startup validating therapeutic targets, or a pharmaceutical team investigating disease mechanisms, Intusomics provides scalable analytical solutions grounded in rigorous biology.

Yes, we offer guidance to help you navigate your analysis confidently.